Literature DB >> 21859679

Hepatorenal syndrome in the intensive care unit.

Hani M Wadei1, Thomas A Gonwa.   

Abstract

Hepatorenal syndrome (HRS) is a functional form of acute kidney injury (AKI) associated with advanced liver cirrhosis or fulminant hepatic failure. Various new concepts have emerged since the initial diagnostic criteria and definition of HRS was initially published. These include better understanding of the pathophysiological mechanisms involved in HRS, identification of bacterial infection (especially spontaneous bacterial peritonitis) as the most important HRS-precipitating event, recognition that insufficient cardiac output plays a role in the occurrence of HRS, and evidence that renal failure reverses with pharmacotherapy. Patients with HRS are often critically ill and, by definition, have multiorgan failure. The purpose of this review is to provide an update on novel advances in HRS, with emphasis on the different aspects of management of these patients in the intensive care unit.

Entities:  

Mesh:

Year:  2011        PMID: 21859679     DOI: 10.1177/0885066611408692

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  5 in total

Review 1.  Hepatorenal syndrome: Update on diagnosis and treatment.

Authors:  Olga Baraldi; Chiara Valentini; Gabriele Donati; Giorgia Comai; Vania Cuna; Irene Capelli; Maria Laura Angelini; Maria Ilaria Moretti; Andrea Angeletti; Fabio Piscaglia; Gaetano La Manna
Journal:  World J Nephrol       Date:  2015-11-06

Review 2.  [Hepatorenal syndrome].

Authors:  G Huschak; U X Kaisers; S Laudi
Journal:  Anaesthesist       Date:  2013-07       Impact factor: 1.041

3.  Updates on Hepato-Renal Syndrome.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Anesth Clin Res       Date:  2013-09-27

4.  Patients with Hepatorenal Syndrome Should Be Dialyzed? CON.

Authors:  Hani M Wadei
Journal:  Kidney360       Date:  2020-12-16

5.  Disrupted Renal Mitochondrial Homeostasis after Liver Transplantation in Rats.

Authors:  Qinlong Liu; Yasodha Krishnasamy; Hasibur Rehman; John J Lemasters; Rick G Schnellmann; Zhi Zhong
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.